Efficacy and safety of ferric citrate on hyperphosphatemia among Chinese patients with chronic kidney disease undergoing hemodialysis: a phase III multicenter randomized open-label active-drug controlled study

CONCLUSION: Ferric citrate capsules have good efficacy and safety in the control of hyperphosphatemia in adult patients with CKD undergoing hemodialysis. Efficacy is not inferior to sevelamer carbonate. The TEAEs were mostly mild and tolerated by the patients.PMID:37812931 | DOI:10.1159/000534484

Source: American Journal of Nephrology - October 9, 2023 Category: Urology & Nephrology Authors: Yong Wang Xiangmei Chen Hanyu Zhu Zhiyong Guo Yibin Yang Ping Luo Yani He Yan Xu Daxi Ji Xinlu Gao Xiuli Sun Changying Xing Yu Wang Xiaohui Wang Shuping Zhao Yan Guan Hongli Lin Aimin Zhong Hua Shui Fengmin Shao Lu Lv Yuehong Yan Xiaokun Sun Lei Zhang Source Type: research